Dr Delia Guaqueta speaks to ecancer about the role of CDK4/6 inhibitors in the treatment of metastatic breast cancer.

She discusses the data from different trials investigating CDK4/6 inhibitors in the treatment of metastatic breast cancer.

Dr Guaqueta talks about drug approvals and concludes by talking about ecancer.

She says ecancer provides a great opportunity to reach all kinds of physicians and physicians in training and provides an international platform to discuss experiences in treating cancer.